4.3 Editorial Material

Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Antidiabetic Sulfonylureas and cAMP Cooperatively Activate Epac2A

Toshimasa Takahashi et al.

SCIENCE SIGNALING (2013)

Review Endocrinology & Metabolism

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

Yutaka Seino et al.

JOURNAL OF DIABETES INVESTIGATION (2013)

Article Multidisciplinary Sciences

The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs

Chang-Liang Zhang et al.

SCIENCE (2009)